Abstract

Introduction: Heart transplant recipients have a significantly higher risk of any “de novo” cancer due to immunosuppressive therapy and also they have an increasing risk of infections. Carcinoma of lung represents one of the five most common malignancies in these transplant populations. Patients’ comorbidities may request high invasive intraoperative monitoring, as well as neuraxial analgesia to avoid acute pain stress response, exposing patients to iatrogenic nosocomial infection. Case Report: Our patient was admitted to thoracic surgery ward for lung adenocarcinoma and video assisted lung lobectomy was planned. She received heart transplantation 15 years before due to idiopathic dilatative cardiomyopathy and she had chronic rejection six years after transplant treated with corticosteroid therapy. Conclusion: Anesthesia management can be difficult in cardiac transplant recipients due to a potentially impaired heart function and hypotension should be avoided due to preload dependence

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.